Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $18.50.
Several brokerages recently issued reports on CLMT. Wells Fargo & Company reduced their target price on Calumet Specialty Products Partners from $23.00 to $21.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. TD Cowen lowered Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and reduced their target price for the company from $26.00 to $16.00 in a research report on Tuesday, March 4th. HC Wainwright reaffirmed a "buy" rating and set a $33.00 target price on shares of Calumet Specialty Products Partners in a research report on Monday, March 3rd. UBS Group raised Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and reduced their target price for the company from $15.00 to $12.00 in a research report on Monday, March 17th. Finally, Bank of America assumed coverage on Calumet Specialty Products Partners in a research note on Tuesday, May 13th. They set a "buy" rating and a $15.00 price target on the stock.
Read Our Latest Analysis on Calumet Specialty Products Partners
Calumet Specialty Products Partners Trading Down 0.3%
Shares of CLMT traded down $0.04 during trading hours on Thursday, hitting $13.78. The company had a trading volume of 617,409 shares, compared to its average volume of 896,270. The company's fifty day moving average price is $11.48 and its two-hundred day moving average price is $16.21. Calumet Specialty Products Partners has a one year low of $7.68 and a one year high of $25.29. The company has a market capitalization of $1.19 billion, a PE ratio of -4.99 and a beta of 0.89.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its earnings results on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.62). The company had revenue of $993.90 million during the quarter, compared to the consensus estimate of $899.62 million. During the same quarter in the prior year, the company earned ($0.51) earnings per share. Calumet Specialty Products Partners's quarterly revenue was down 1.2% compared to the same quarter last year. Analysts forecast that Calumet Specialty Products Partners will post -3.02 earnings per share for the current year.
Insider Buying and Selling at Calumet Specialty Products Partners
In other news, CFO David Lunin purchased 2,500 shares of the company's stock in a transaction on Tuesday, March 4th. The shares were acquired at an average price of $13.05 per share, for a total transaction of $32,625.00. Following the purchase, the chief financial officer now owns 2,500 shares in the company, valued at $32,625. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Stephen P. Mawer sold 3,655 shares of the firm's stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $12.88, for a total value of $47,076.40. Following the sale, the director now directly owns 287,307 shares in the company, valued at approximately $3,700,514.16. This trade represents a 1.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.91% of the company's stock.
About Calumet Specialty Products Partners
(
Get Free ReportCalumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Further Reading

Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.